Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $80.79 ($527K) on 2016-10-12, disclosed to the SEC on 2016-10-14.
Scheduled sale ($527k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.79 | 4,100 | $331K | 62.8% |
| 2 | $81.28 | 1,400 | $114K | 21.6% |
| 3 | $82.35 | 1,000 | $82K | 15.6% |
| Total | $81.14 avg | 6,500 | $527K | 100% |
| Filing → |
| VRTX | SELL | 2017-01-06 | $501K | — | Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-22 | $482K | — | Filing → |